Literature DB >> 11684292

Molecular cloning of a C-type lectin superfamily protein differentially expressed by CD8alpha(-) splenic dendritic cells.

I Caminschi1, K M Lucas, M A O'Keeffe, H Hochrein, Y Laâbi, T C Brodnicki, A M Lew, K Shortman, M D Wright.   

Abstract

Dendritic cells (DC) are potent antigen presenting cells that activate naive T cells. It is becoming increasingly clear that DC are not a homogeneous cell population, but comprise different subpopulations that differ in ontogeny and function. To further the molecular characterisation of DC, we screened for genes that were differentially expressed amongst DC subsets and could therefore give insight into their varying biological functions. Using Representational Difference Analysis (RDA) we identified a gene (CIRE) that is expressed at higher levels in the myeloid-related CD8alpha(-) DC than in the lymphoid-related CD8alpha(+) DC. CIRE is a 238 amino acid type II membrane protein, of approximately 33 kDa in size, whose extracellular region contains a C-type lectin domain. Northern blot analysis revealed that CIRE is almost exclusively expressed in DC and was not detected in organs such as heart, brain, kidney, liver, and thymus. T cells failed to express message for CIRE, whilst B cells expressed very low levels. These data here further substantiated by Northern blot analysis of 18 cell lines of various origins (myeloid, macrophage, B and T cell) where only one cell line, which was of myeloid origin and could give rise to DC, expressed mRNA for CIRE. Semi-quantitative RT-PCR suggested that CIRE is down-regulated upon activation. CIRE shares 57% identity with human DC-SIGN, a molecule that has been shown to be the ligand of ICAM-3 and that is also a receptor that binds HIV and facilitates trans-infection of T cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684292     DOI: 10.1016/s0161-5890(01)00067-0

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  15 in total

1.  DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus.

Authors:  Andrea Marzi; Thomas Gramberg; Graham Simmons; Peggy Möller; Andrew J Rennekamp; Mandy Krumbiegel; Martina Geier; Jutta Eisemann; Nadine Turza; Bertrand Saunier; Alexander Steinkasserer; Stephan Becker; Paul Bates; Heike Hofmann; Stefan Pöhlmann
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

2.  Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer.

Authors:  James Krempski; Lavakumar Karyampudi; Marshall D Behrens; Courtney L Erskine; Lynn Hartmann; Haidong Dong; Ellen L Goode; Kimberly R Kalli; Keith L Knutson
Journal:  J Immunol       Date:  2011-05-06       Impact factor: 5.422

3.  New monoclonal anti-mouse DC-SIGN antibodies reactive with acetone-fixed cells.

Authors:  Cheolho Cheong; Ines Matos; Jae-Hoon Choi; Joseph D Schauer; Durga Bhavani Dandamudi; Elina Shrestha; Jessy A Makeyeva; Xiaojun Li; Pingwei Li; Ralph M Steinman; Chae Gyu Park
Journal:  J Immunol Methods       Date:  2010-06-15       Impact factor: 2.303

4.  Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission.

Authors:  Li Wu; Thomas D Martin; Rosemay Vazeux; Derya Unutmaz; Vineet N KewalRamani
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  DEC-205 is a cell surface receptor for CpG oligonucleotides.

Authors:  Mireille H Lahoud; Fatma Ahmet; Jian-Guo Zhang; Simone Meuter; Antonia N Policheni; Susie Kitsoulis; Chin-Nien Lee; Meredith O'Keeffe; Lucy C Sullivan; Andrew G Brooks; Richard Berry; Jamie Rossjohn; Justine D Mintern; Javier Vega-Ramos; Jose A Villadangos; Nicos A Nicola; Michel C Nussenzweig; Katryn J Stacey; Ken Shortman; William R Heath; Irina Caminschi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

6.  Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells.

Authors:  Eddie W Adams; Daniel M Ratner; Peter H Seeberger; Nir Hacohen
Journal:  Chembiochem       Date:  2008-01-25       Impact factor: 3.164

7.  Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulus.

Authors:  Meredith O'Keeffe; Hubertus Hochrein; David Vremec; Irina Caminschi; Joanna L Miller; E Margot Anders; Li Wu; Mireille H Lahoud; Sandrine Henri; Bernadette Scott; Paul Hertzog; Lilliana Tatarczuch; Ken Shortman
Journal:  J Exp Med       Date:  2002-11-18       Impact factor: 14.307

8.  SIGN-R1 contributes to protection against lethal pneumococcal infection in mice.

Authors:  Astrid Lanoue; Menna R Clatworthy; Philippa Smith; Sheila Green; Michael J Townsend; Helen E Jolin; Kenneth G C Smith; Padraic G Fallon; Andrew N J McKenzie
Journal:  J Exp Med       Date:  2004-12-06       Impact factor: 14.307

Review 9.  Targeting antigens to dendritic cell receptors for vaccine development.

Authors:  Vasso Apostolopoulos; Theresia Thalhammer; Andreas G Tzakos; Lily Stojanovska
Journal:  J Drug Deliv       Date:  2013-10-08

Review 10.  The role of dendritic cells in graft-versus-tumor effect.

Authors:  Tomomi Toubai; Nathan Mathewson; Pavan Reddy
Journal:  Front Immunol       Date:  2014-02-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.